THE WOODLANDS, Texas, July 1 /PRNewswire/ -- eCardio Diagnostics, one of the nation's leading providers of arrhythmia monitoring services, today announced that it has received a significant minority investment from Sequoia Capital. This is eCardio's first round of institutional funding since the company was founded in 2004.
"The investment by Sequoia Capital marks a milestone in the growth of eCardio," noted Larry Lawson, President and Chief Executive Officer. "This partnership will strengthen our technology offering and accelerate our ability to develop fast, flexible and accurate solutions for remote cardiac monitoring."
The investment from Sequoia Capital comes after several years of profitable growth and industry recognition for eCardio.
"eCardio has experienced tremendous growth by meeting the needs of physicians and the patients they serve," stated Sequoia Capital's Scott Carter. "We are excited to partner with a company that provides doctors with the most advanced cardiac diagnostic and monitoring solutions."
About eCardio Diagnostics
eCardio Diagnostics, www.ecardio.com, is one of the nation's leading providers of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in an ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses--contributing to the timeliest, most effective and appropriate management of cardiac patients.
About Sequoia Capital
Since 1972, Sequoia Capital has provided early stage and growth stage venture
|SOURCE eCardio Diagnostics|
Copyright©2009 PR Newswire.
All rights reserved